Back to History Current Version

Testing an investment readiness program for start-ups

Last registered on December 08, 2015

Pre-Trial

Trial Information

General Information

Title
Testing an investment readiness program for start-ups
RCT ID
AEARCTR-0000895
Initial registration date
October 02, 2015

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 02, 2015, 5:23 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
December 08, 2015, 5:31 PM EST

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Primary Investigator

Affiliation
World Bank

Other Primary Investigator(s)

PI Affiliation
University of Lausanne
PI Affiliation
World Bank

Additional Trial Information

Status
On going
Start date
2015-08-14
End date
2018-12-15
Secondary IDs
Abstract
The team wants to test the impact of an Investment Readiness Program (IRP) that is geared to facilitate access to equity finance for innovative start-ups and SMEs. Lack of access to equity finance for innovative start-ups and SMEs has been recognized as a major problem in the region, and there is a belief that many firms have good ideas but lack the necessary know-how and preparedness to be ready to pitch their ideas to external investors. The investment readiness program is aimed at getting firms ready for a pitch event, through a combination of training, mentoring, master classes, pitch practice, and other assistance.
External Link(s)

Registration Citation

Citation
Cusolito, Ana Paula, Ernest Dautovic and David McKenzie. 2015. "Testing an investment readiness program for start-ups." AEA RCT Registry. December 08. https://doi.org/10.1257/rct.895-4.0
Former Citation
Cusolito, Ana Paula, Ernest Dautovic and David McKenzie. 2015. "Testing an investment readiness program for start-ups." AEA RCT Registry. December 08. https://www.socialscienceregistry.org/trials/895/history/6260
Experimental Details

Interventions

Intervention(s)
A sample of 346 firms were randomly divided into two groups: a treatment group of 174 which receives the investment readiness program, and a control group of 172 which does not. The investment readiness program consists of a combination of training, mentoring, master classes, networking, and pitch preparation. Both groups will then pitch their businesses in a venture forum, and will be scored by judges to measure their investment readiness. They will then be tracked over time to see the extent to which this translates into longer-term business outcomes.
Intervention (Hidden)
Intervention Start Date
2015-09-15
Intervention End Date
2015-12-15

Primary Outcomes

Primary Outcomes (end points)
The key short-term outcomes are:
- Investment Readiness: a score of how investible the firm is, according to scores by judges in a pitch competition. The pre-analysis plan provides details on how this will be measured.
- Initial investment made: a binary variable of whether an initial investment offer is made by an investor participating in the pitch competition/venture forum.

Longer-term outcomes are:
- Business survival
- Whether or not they have an external investor
- Business growth as measured by:
- Employment as measured through a survey
- Sales as measured through a survey
- online activity as measured by Alexa
- appearance in news articles as measured by Lexis/Nexis or Meltwater
- appearance in Angel List
- number of followers on LinkedIn, twitter and facebook
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
The firms are randomized at the individual level into a treatment group and a control group
Experimental Design Details
Applications were screened to ensure they meet the eligibility requirements. Eligible applications were then scored on four criteria to measure their initial level of investment readiness: market attractiveness, product technology, traction, and team. The top 10 proposals overall in terms of score were then randomly assigned to 5 in treatment and 5 in control, in order to ensure that some of the very top proposals were in both groups. Then the remainder of firms were divided into groups (strata) based on country (Serbia, Croatia, or the rest) and whether or not they already have a private investor. Within these six groups firms were ranked into groups of four on the basis of their investment readiness score. Within these quartets two firms were randomly chosen for treatment and two for control.
This was done for an initial batch of 335 firms, allocating 167 to treatment and 168 to control. A batch of 12 additional firms whose details had taken longer to check were then received. These were stratified into three quartets based on score, with firms then randomly assigned to treatment and control within quartet. Finally one last firm was received, and a single random draw used to assign this to treatment. This resulted in 348 firms, with 174 treatment and 174 control. Two duplicates were dropped resulting in a final sample of 346.
Randomization Method
Randomization done in office by a computer
Randomization Unit
Individual firm
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
346 firms
Sample size: planned number of observations
346 firms
Sample size (or number of clusters) by treatment arms
174 treated, 172 control
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Initial investment readiness has a mean of approximately 3 and standard deviation of 0.75 (on a score out of 5). The minimal detectable effect is a 0.18 increase in investment readiness, assuming an autocorrelation of 0.6. This equates to 0.24 standard deviations: sampsi 3 3.18, n1(172) n2(174) sd1(0.75) pre(1) post(1) r01(0.6)
IRB

Institutional Review Boards (IRBs)

IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

Analysis Plan Documents

Pre-analysis plan (November 10, 2015 update)

MD5: 606c4a4d99f8330188398008ae0dc596

SHA1: d08f9db88f51d90134efbc8709b19348f375a715

Uploaded At: November 10, 2015

Pre-analysis plan

MD5: 6e2cb612f2b02ce1316fbe5eb8c6a668

SHA1: 60468a543f8bccf3adeebd659f2f8bee2d277515

Uploaded At: November 06, 2015

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials